dr. fuqua on esr1 mutations in primary breast cancer
Published 10 years ago • 250 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
0:53
suzanne a. w. fuqua, phd, on targeting the androgen receptor in breast cancer
-
1:00
dr. fuqua on the interaction between er and ar in breast cancer
-
1:47
dr. goncalves describes research involving the esr1 mutation in breast cancer
-
1:58
dr. tolaney on presence of pik3ca and esr1 mutations in monarch 2 trial in breast cancer
-
4:48
breast cancer breakthroughs: the importance of esr1 mutations in metastatic breast cancer
-
2:06
elaine 1: esr1 mutations in ctdna from er /her2- mbc treated with lasofoxifene or fulvestrant
-
1:01
dr. graff on current treatments in esr1-mutant breast cancer
-
1:12
dr. graff underscores unmet needs in esr1-mutated breast cancer
-
1:19
suzanne fuqua discusses y537 hotspot in breast cancer
-
2:32
dr. goetz on treatment challenges for esr1-mutant breast cancer
-
1:32
suzanne a. w. fuqua, phd, discusses the androgen receptor in breast cancer
-
1:29
dr. cristofanilli on lasofoxifene in esr1-mutant breast cancer
-
1:02:29
understanding progression: how to identify and treat esr1 mutations in hr mbc
-
20:05
esr1 mutation: the need for & role of testing in er / her2- advanced or metastatic breast cancer
-
2:35
lasofoxifene shows promise for women with esr1-mutated mbc
-
1:10
dr. cristofanilli on data with lasofoxifene in esr1-mutant breast cancer
-
4:34
lasofoxifene vs fulvestrant for locally advanced/metastatic er /her2- breast cancer: elaine trial
-
1:47
an overview of the ma17r trial in breast cancer
-
8:05
metastatic breast cancer: estrogen receptor mutations detected are associated with worse survival